What the Media isn’t Telling You About Bioidentical Hormones

Recently, a new analysis of the women involved in the Women’s Health Initiative (WHI) was published in the October 20th issue of the Journal of the American Medical Association. In the new report, researchers have found that hormone replacement therapy not only increased the risk of breast cancer in women, but also the likelihood that she would die from the disease. While these findings may seem alarming at first, it’s important that you don’t let the media scare you into believing that all hormones are bad for you.

Taking Hormone Therapy? Don’t Panic

I know that my patients and their friends are an internet and media savvy group. As such, I am sure they are aware of the recently released JAMA (Journal of the American Medical Association) article that dealt with the incidence of breast cancer in patients undergoing long-term follow-up in the Women’s Health Initiative (WHI) studies. This study was released several years ago after analyzing the results of giving hormone replacement therapy (HRT) in the form of synthetic Progestins (progesterone-like molecules) and Estrogens (Premarin) derived from horse urine which are most definitely NOT the same as human estrogen. Ultimately the study was discontinued because of the statistically increased incidence of cardiovascular disease and uterine cancer. The most recent data analysis looks at the incidence of breast cancer and it’s complications in women from the original study who were followed for an additional 4 years. The results showed that there was a significantly increased incidence of breast cancer as well as the metastatic consequences of those cancers in the women who were given the synthetic hormones.

Dr. Melinda Silva Discusses Hormone Therapy and Breast Cancer Risk

In a new analysis of the women involved in the Women’s Health Initiative (WHI), researchers discovered that synthetic hormone replacement therapy used after menopause not only increased the risk of breast cancer in women, but also increased their risk of dying from the disease, when compared with women who did not receive treatment. These new findings were recently published in the October 20th issue of the Journal of the American Medical Association. The WHI was a federally funded study that analyzed more than16,500 postmenopausal women who were given either hormone replacement therapy or a placebo.

Puzzled About Hormone Therapy?

Recently, a new analysis of the women involved in the Women’s Health Initiative (WHI) was published in October 20th issue of the Journal of the American Medical Association (JAMA). In the new report, researchers have found that hormone replacement therapy not only increased the risk of breast cancer in women, but also the likelihood that she would die from the disease. While these findings may seem alarming at first, it’s important that you don’t let the media scare you into believing that all hormones are bad for you.

More on Big Pharm's Big Bust

One of the main criticisms of bioidentical hormone therapy is that “there are no studies on bioidentical hormones.” In fact, there are many excellent publications that demonstrate the benefits of bioidentical hormone therapy. Some of the studies show a greater margin of safety with bioidentical progesterone over the non-bioidentical progestin, Provera. Those that support Premarin and Provera point to a number of studies that were done. However, 26 of them were biased and, what’s worse, the bias was covered up. If Wyeth needed to “give credit” to other physicians for their research on their own products, what were they trying to cover up? What did they know that they weren’t saying? Why weren’t there independent groups that could have demonstrated the benefits of Premarin and Provera?

Newsweek Attacks Oprah, BodyLogicMD Speaks Out

Newsweek recently published a scathing article about Oprah titled “Why Health Advice on Oprah could make you sick.” In it, Weston Kosova and Pat Wingert criticize Oprah for having Suzanne Somers on her show as the “expert” on bioidentical hormones. Dr. Alicia Stanton, CMO of BodyLogicMD shares her thoughts on Kosova and Wingert’s criticisms.

BodyLogicMD's CMO Responds to Newsweek's Recent Article on Oprah and Somers

I know that there is a middle ground in the bioidentical hormone debate. Suzanne Somers is on one side of the debate. I would welcome another show with Dr. Streicher, Dr. Northrup and a few doctors who use the lower dose regimens and combinations of pharmaceutical and compounded prescriptions. Many of the physicians trained by the American Academy of Anti-Aging and the Institute of Functional Medicine practice in a more conservative manner than what was described on Oprah’s shows. Overall, I love the conversation and the fact that there are so many points of view. It gives everyone a chance to ask questions and learn more for themselves.